SCHEMBL26134270

SCHEMBL26134270

CC(CCC(=O)N1CCCC1C(N)=O)c1ccno1

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 8/20 0.45
▸ HTR1A P08908 11/20 0.44
▸ HTR7 P34969 11/20 0.44
▸ ACE P12821 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26223783 0.76 DPP4 (0.48) DPP4HTR1AHTR7ACE
SCHEMBL19111008 0.76 DPP4 (0.48) DPP4HTR1AHTR7ACE
SCHEMBL30874915 0.76 DPP4 (0.45) DPP4HTR1AHTR7ACE
SCHEMBL29540069 0.69 DPP4 (0.53) DPP4HTR1AHTR7ACE
SCHEMBL14463150 0.69 DPP4 (0.51) DPP4HTR1AHTR7ACE
SCHEMBL30874974 0.68 DPP4 (0.44) DPP4HTR1AHTR7ACE
SCHEMBL30874846 0.68 DPP4 (0.47) DPP4HTR1AHTR7
SCHEMBL12863842 0.68 SMN1; SMN2 (0.47) DPP4HTR1AHTR7ACE
SCHEMBL10884099 0.68 DPP4 (0.54) DPP4HTR1AHTR7ACE
SCHEMBL13954202 0.68 DPP4 (0.51) DPP4HTR1AHTR7ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
WO-2023069514-A2 BIFUNCTIONAL COMPOUNDS FOR DEGRADING ITK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback